幽門螺旋桿菌檢測市場規模、佔有率和成長分析：按檢測類型、技術、最終用戶、應用和地區分類－2026-2033年產業預測

2024 年全球幽門螺旋桿菌檢測市場價值為 4.862 億美元，預計到 2025 年將成長至 5.1683 億美元，到 2033 年將成長至 8.4259 億美元，在預測期（2026-2033 年）內複合年成長率為 6.3%。

人們對幽門螺旋桿菌作為胃炎、消化性潰瘍和胃癌可治療病因的認知不斷提高，這正顯著影響著全球檢測市場。這種認知的提高使醫療專業人員能夠有效地識別和管理感染。該市場涵蓋多種診斷方法，例如尿素呼吸檢測、糞便抗原檢測和分子診斷。早期發現對於減少健康併發症至關重要。尤其是在抗生素抗藥性日益嚴重的背景下，人們明顯從侵入性檢查轉向非侵入性檢測方法。這推動了對能夠識別抗藥性的先進診斷技術的需求。此外，人工智慧 (AI) 透過最佳化工作流程和支援檢查室的精確分析來提高診斷準確性，最終為製造商創造商機並有助於改善患者照護。

全球幽門螺旋桿菌檢測市場的成長要素

全球幽門螺旋桿菌檢測市場正在成長，這主要得益於非侵入性檢測方法（包括糞便抗原檢測和呼吸檢測）的日益普及。這些檢測方法提高了患者的便利性，並消除了檢體採集的障礙，促使臨床醫生建議患者更頻繁地進行檢測，並在疾病早期階段進行檢測。隨著患者對這些檢測方法的接受度提高，篩檢參與率也顯著增加。此外，這些檢測方案與基層醫療機構的無縫銜接，也鼓勵了醫療專業人員更積極地採用這些方法。所有這些因素共同推動了檢測市場的應用成長和商業性發展。

全球幽門螺旋桿菌檢測市場面臨的限制因素

全球幽門螺旋桿菌檢測市場面臨許多挑戰，包括許多地區缺乏檢測基礎設施和訓練有素的人員，阻礙了診斷服務的可及性和可靠性。供應鏈不穩定和診所設備短缺使得醫療機構難以持續進行檢測，導致醫師轉診量減少，病患參與度下降。此外，檢體運輸問題和檢測結果出具速度緩慢也削弱了人們對診斷過程的信心，抑制了製造商和醫療系統的投資意願。最終，這些因素阻礙了相關市場對檢測技術的廣泛應用和商業化。

全球幽門螺旋桿菌檢測市場趨勢

全球幽門螺旋桿菌檢測市場正經歷著向非侵入性檢測方法的顯著轉變，尤其是呼吸檢測和糞便抗原檢測，這主要得益於人們越來越重視患者的舒適度和檢體採集的便利性。這一趨勢正在改善基層醫療和門診機構的檢測可及性，簡化診斷流程，並推廣「檢測即治療」策略，從而避免了侵入性內視鏡檢查。隨著研發人員致力於快速報告結果、簡化工作流程和開發方便用戶使用的試劑盒，檢測流程的依從性將得到提升，最終將促進這些檢測方法在各種臨床環境中更廣泛、更永續應用，並全面提升患者照護品質。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球幽門螺旋桿菌檢測市場規模：依檢測類型分類

• 非侵入性檢查
• 侵入性檢查
  • 快速尿素酶試驗（RUT）
  • 組織學
  • 培養試驗
  • 分子診斷（PCR 及其他）

全球幽門螺旋桿菌檢測市場規模：依技術分類

• 免疫測量
• 分子診斷
• 微生物培養法
• 基於組織病理學的方法
• 呼吸分析技術

全球幽門螺旋桿菌檢測市場規模：依最終用戶分類

• 醫院
• 診斷檢查室
• 專科胃腸病診所
• 學術研究機構

全球幽門螺旋桿菌檢測市場規模：按應用領域分類

• 初步診斷
• 治療後監測和根除確認
• 出於研究目的

全球幽門螺旋桿菌檢測市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• DiaSorin SpA
• QuidelOrtho Corporation
• Meridian Bioscience, Inc.
• Sekisui Diagnostics, LLC
• Coris BioConcept SA
• Certest Biotec SL
• Diagnostic BioSystems, Inc.
• Trinity Biotech plc
• Acon Laboratories, Inc.
• Alfa Scientific Designs, Inc.
• CerTest Diagnostics GmbH
• Linear Chemicals SLU
• SD Biosensor, Inc.
• Bioneer Corporation
• Biomerica, Inc.

結論與建議

Global Helicobacter Pylori Testing Market size was valued at USD 486.2 Million in 2024 and is poised to grow from USD 516.83 Million in 2025 to USD 842.59 Million by 2033, growing at a CAGR of 6.3% during the forecast period (2026-2033).

The increasing awareness of Helicobacter pylori as a treatable cause of gastritis, peptic ulcer disease, and gastric cancer is significantly influencing the global testing market. This awareness drives healthcare providers to identify and address infections effectively. The market includes various diagnostics, such as urea breath tests, stool antigen assays, and molecular methods. Timely detection plays a critical role in reducing health complications. The shift from invasive procedures to non-invasive testing methods has been notable, especially with the rise in antibiotic resistance. This has led to a growing demand for advanced diagnostics capable of identifying resistance. Additionally, artificial intelligence is enhancing diagnostic precision by optimizing workflows and supporting accurate analyses in laboratory settings, ultimately fostering opportunities for manufacturers and improving patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Helicobacter Pylori Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Helicobacter Pylori Testing Market Segments Analysis

Global helicobacter pylori testing market is segmented by test type, technology, end user, application and region. Based on test type, the market is segmented into Non-Invasive Tests and Invasive Tests. Based on technology, the market is segmented into Immunoassays, Molecular Diagnostics, Microbiological Culture Methods, Histopathology-Based Methods and Breath Analysis Technologies. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Specialty Gastroenterology Clinics and Academic & Research Institutes. Based on application, the market is segmented into Initial Diagnosis, Post-Treatment Monitoring & Eradication Confirmation and Research Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Helicobacter Pylori Testing Market

The Global Helicobacter Pylori Testing market is experiencing growth driven by the rising acceptance of noninvasive testing methods, including stool antigen assays and breath tests. These options enhance patient convenience and eliminate barriers associated with sample collection, prompting clinicians to recommend testing more often and at earlier stages. As patients feel more at ease with these methods, their participation in screening initiatives rises significantly. Additionally, the seamless integration of these testing solutions into primary care practices encourages healthcare providers to adopt them more readily. This combination of factors is collectively fueling increased utilization and commercial expansion within the testing market.

Restraints in the Global Helicobacter Pylori Testing Market

The Global Helicobacter Pylori Testing market faces significant challenges due to insufficient laboratory infrastructure and a lack of trained personnel in various regions, which hampers the availability and reliability of diagnostic services. In scenarios where clinics experience unreliable supply chains and inadequate equipment, healthcare providers encounter difficulties in delivering consistent testing, resulting in fewer clinician referrals and reduced patient engagement. Additionally, complications regarding specimen transport and the timeliness of results erode confidence in the diagnostic process, dissuading both manufacturers and health systems from investing. This ultimately hinders the widespread adoption and commercialization of testing technologies in these impacted markets.

Market Trends of the Global Helicobacter Pylori Testing Market

The Global Helicobacter Pylori Testing market is witnessing a significant shift towards noninvasive testing methods, particularly breath and stool antigen assays, driven by an emphasis on patient comfort and ease of sample collection. This trend enhances accessibility to testing in primary care and outpatient settings, streamlining diagnostic processes and fostering test-and-treat strategies that eliminate the need for invasive endoscopy. As developers focus on creating rapid turnaround times, simplified workflows, and user-friendly kits, the market is likely to see increased adherence to testing protocols, ultimately supporting broader and more sustainable implementation across various clinical practices and enhancing overall patient care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Helicobacter Pylori Testing Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Non-Invasive Tests
• Invasive Tests
  • Rapid Urease Test (RUT)
  • Histology
  • Culture Test
  • Molecular Diagnostics (PCR & Others)

Global Helicobacter Pylori Testing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunoassays
• Molecular Diagnostics
• Microbiological Culture Methods
• Histopathology-Based Methods
• Breath Analysis Technologies

Global Helicobacter Pylori Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Specialty Gastroenterology Clinics
• Academic & Research Institutes

Global Helicobacter Pylori Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Initial Diagnosis
• Post-Treatment Monitoring & Eradication Confirmation
• Research Applications

Global Helicobacter Pylori Testing Market Size & CAGR (2026-2033)

• North America (Test Type, Technology, End User, Application)
  • US
  • Canada
• Europe (Test Type, Technology, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Technology, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Technology, End User, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Technology, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coris BioConcept SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certest Biotec S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostic BioSystems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acon Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alfa Scientific Designs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CerTest Diagnostics GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linear Chemicals S.L.U.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioneer Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerica, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations